Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Magainin analogues reported by Scripps

Feb. 6, 1997

Cephems in development at Meiji Seika

Feb. 6, 1997

Takeda discloses novel cephems

Feb. 5, 1997

U.S. patent for Tularik drug discovery assays

Feb. 4, 1997

Takeda's new cephems

Feb. 4, 1997

Novel formulation of aciclovir enters pivotal trials

Jan. 31, 1997

Micrologix receives broad patent coverage for peptide antibiotic production method

Jan. 31, 1997

Novel antiinfective agents from Tanabe

Jan. 31, 1997

Bayer to market Amphotec in Canada

Jan. 30, 1997

Nobel Laureate to study bacterial resistance to nisin

Jan. 30, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...